首页 > 最新文献

Journal of minimally invasive gynecology最新文献

英文 中文
Cross Sectional Survey of Ob/Gyn Residents' Graduated Experience With Robotic Surgery. 妇产科住院医师毕业时机器人手术经验的横断面调查。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2024-09-17 DOI: 10.1016/j.jmig.2024.09.008
Alexandra E Snyder, Lauren E Farmer, Morgan L Cheeks, Erin J Caraher, Jasmine Correa, Natalia S Parra, Julia J Wainger, Ayesha I Yakubu, Samantha D Buery-Joyner

Study objective: Obstetrics and gynecology (Ob/Gyn) resident experience with robotic gynecologic surgery has been evaluated at time of graduation, but no specific surgical procedures were identified to differentiate the experiences of residents at each level. This study proposes to determine which factors are correlated with more hands-on robotic surgery experience and resident satisfaction.

Design: An Investigational Review Board-approved, 15-question survey was distributed electronically. Ninety-eight responses were received for a rate of 44%. Linear regression and Analysis of Variance statistical analysis were performed.

Setting: Current residents at 8 Ob/gyn residency programs in the US were surveyed.

Patients: N/A.

Interventions: Survey administration.

Measurement and main results: The majority of respondents were satisfied (48%) or had neutral feelings (20%) with regard to their robotic surgery experience. All respondents reported experience with uterine manipulation or bedside assistance by postgraduate year (PGY) 2. Earliest experience performing hysterectomy was most common in PGY2 or PGY3. Seventy-six percent of PGY3 or PGY4 residents report operating on the console for some or all major robotic surgeries, with 69% having participated in greater than 20 robotic surgery cases during residency. Only exposure to Minimally Invasive Gynecologic Surgery faculty is significantly associated with high robotic surgery experience (p = .022). Overall satisfaction with robotic surgery experience increased significantly with higher level of participation (p <.0001), particularly operating at the console during some or most of the surgery; longitudinal experiences with hysterectomy, myomectomy, and salpingectomy/oophorectomy (p <.05); but not with sole bedside assisting or vaginal cuff closure. Factors limiting robotic console experience included case time constraints, lack of first assists, case complexity, and attending comfort.

Conclusions: Ob/Gyn resident satisfaction with training is significantly related to level and duration of robotic surgery participation. Minimally Invasive Gynecologic Surgery faculty contribute to more resident experience, and limiting factors include time constraints, case complexity, and lack of first assists. These results can provide a framework for structuring resident training in robotic surgery.

研究目的:妇产科住院医师在毕业时对机器人妇科手术的经验进行了评估,但没有确定具体的手术程序来区分每个级别住院医师的经验。本研究旨在确定哪些因素与更多的机器人手术实践经验和住院医师满意度相关:设计:通过电子方式分发了一份经 IRB 批准、包含 15 个问题的调查问卷。共收到 98 份回复,回复率为 44%。进行了线性回归和方差分析:调查对象: 美国八个妇产科住院医师培训项目的在读住院医师:无干预措施:测量和主要结果:大多数受访者对机器人手术体验表示满意(48%)或中性(20%)。所有受访者都表示在第二年级之前有过子宫操作或床边辅助的经验。最早有子宫切除术经验的是 PGY2 或 PGY3。76%的 PGY3 或 PGY4 住院医师表示在控制台上操作过部分或全部大型机器人手术,其中 69% 在住院医师培训期间参与过 20 例以上的机器人手术。只有与MIGS教师的接触才与丰富的机器人手术经验显著相关(p=.022)。对机器人手术经验的总体满意度随着参与程度的提高而显著增加(p结论:妇产科住院医师对培训的满意度与参与机器人手术的水平和持续时间密切相关。MIGS师资有助于增加住院医师的经验,限制因素包括时间限制、病例复杂性和缺乏第一助手。这些结果可为住院医师机器人手术培训的结构提供一个框架。
{"title":"Cross Sectional Survey of Ob/Gyn Residents' Graduated Experience With Robotic Surgery.","authors":"Alexandra E Snyder, Lauren E Farmer, Morgan L Cheeks, Erin J Caraher, Jasmine Correa, Natalia S Parra, Julia J Wainger, Ayesha I Yakubu, Samantha D Buery-Joyner","doi":"10.1016/j.jmig.2024.09.008","DOIUrl":"10.1016/j.jmig.2024.09.008","url":null,"abstract":"<p><strong>Study objective: </strong>Obstetrics and gynecology (Ob/Gyn) resident experience with robotic gynecologic surgery has been evaluated at time of graduation, but no specific surgical procedures were identified to differentiate the experiences of residents at each level. This study proposes to determine which factors are correlated with more hands-on robotic surgery experience and resident satisfaction.</p><p><strong>Design: </strong>An Investigational Review Board-approved, 15-question survey was distributed electronically. Ninety-eight responses were received for a rate of 44%. Linear regression and Analysis of Variance statistical analysis were performed.</p><p><strong>Setting: </strong>Current residents at 8 Ob/gyn residency programs in the US were surveyed.</p><p><strong>Patients: </strong>N/A.</p><p><strong>Interventions: </strong>Survey administration.</p><p><strong>Measurement and main results: </strong>The majority of respondents were satisfied (48%) or had neutral feelings (20%) with regard to their robotic surgery experience. All respondents reported experience with uterine manipulation or bedside assistance by postgraduate year (PGY) 2. Earliest experience performing hysterectomy was most common in PGY2 or PGY3. Seventy-six percent of PGY3 or PGY4 residents report operating on the console for some or all major robotic surgeries, with 69% having participated in greater than 20 robotic surgery cases during residency. Only exposure to Minimally Invasive Gynecologic Surgery faculty is significantly associated with high robotic surgery experience (p = .022). Overall satisfaction with robotic surgery experience increased significantly with higher level of participation (p <.0001), particularly operating at the console during some or most of the surgery; longitudinal experiences with hysterectomy, myomectomy, and salpingectomy/oophorectomy (p <.05); but not with sole bedside assisting or vaginal cuff closure. Factors limiting robotic console experience included case time constraints, lack of first assists, case complexity, and attending comfort.</p><p><strong>Conclusions: </strong>Ob/Gyn resident satisfaction with training is significantly related to level and duration of robotic surgery participation. Minimally Invasive Gynecologic Surgery faculty contribute to more resident experience, and limiting factors include time constraints, case complexity, and lack of first assists. These results can provide a framework for structuring resident training in robotic surgery.</p>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":"49-56"},"PeriodicalIF":3.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regarding "Outcomes of Vaginal Repair and Vaginal Repair Combined With GnRHa Administration in the Treatment of Cesarean Section Scar Defects: A Randomized Clinical Trial". 关于 "阴道修复术和阴道修复术联合应用 GnRHa 治疗剖宫产瘢痕缺损的结果:随机临床试验"。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2024-09-26 DOI: 10.1016/j.jmig.2024.08.023
Junfei Li, Dan Liao
{"title":"Regarding \"Outcomes of Vaginal Repair and Vaginal Repair Combined With GnRHa Administration in the Treatment of Cesarean Section Scar Defects: A Randomized Clinical Trial\".","authors":"Junfei Li, Dan Liao","doi":"10.1016/j.jmig.2024.08.023","DOIUrl":"10.1016/j.jmig.2024.08.023","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":"72"},"PeriodicalIF":3.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142348445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case Control Study of vNOTES Versus Conventional Laparoscopic Salpingectomy for Ectopic Pregnancy. vNOTES与传统腹腔镜输卵管切除术治疗宫外孕的病例对照研究。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2024-08-30 DOI: 10.1016/j.jmig.2024.08.016
Wai Yoong, Joachim Ho, Vanessa Mathieu, Sarah Wylie, Wasim Lodhi, Schahrazed Rouabhi

Study objective: While the laparoscopic approach is the surgical treatment of choice for ectopic pregnancy, vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) is emerging as an alternative route with its good optical visibility and avoidance of abdominal incisions. The authors compare demographics and outcome data of vNOTES vs conventional laparoscopic (CL) salpingectomy for the surgical management of ectopic pregnancy.

Design: Case-control study.

Setting: A London University hospital.

Patients: Women with ectopic pregnancy unsuitable for medical management who underwent surgical management.

Intervention: Twenty-five cases of vNOTES vs 25 CL salpingectomy.

Measurements and main results: The mean patient age (29.7 ± 53 vs 31.4 ± 6.7 days), parity (1.2 ± 1.1 vs 1.6 ± 2.1), body mass index (26.7 ± 5.3 vs 27.2 ± 5.4 kg/m3), gestation age (8.44 ± 2.1 vs 7.3 ± 1.7 weeks) and β human chorionic gonadotrophin (βhCG) levels (3725.4 ± 3674.8 vs 4376.5 ± 6493.4 IU/liter) were comparable (p >.05, t test) between patients having vNOTES vs CL salpingectomy. While estimated blood loss was similar (218.2 ± 491.7 vs 173.5 ± 138.7 mL) (p >.001), vNOTES patients had a statistically shorter duration of surgery (35.8 ± 14.4 vs 75.8 ± 19.7 mins) (p <.001, t test) and length of stay (median: 11.5 vs 19.7 hours) (U = 72, p <.05, Mann-Whitney U test). Less patients in the vNOTES group required postoperative opioids (9% vs 25%), and the median visual analog score (/10) for pain at 24 hours was significantly lower (2.0 vs 4.0) (U = 75, p <.05, Mann-Whitney U test). Patients from the vNOTES group were able to return to normal daily activity 11.3 days quicker (5.8 ± 4.3 vs 17.1 ± 8.2 days) (p <.05, t test). vNOTES cases cost approximately USD150 more due to the price of the commercial kits but this is offset by reduced intraoperative time, length of stay and need for postprocedure analgesia.

Conclusion: Patients undergoing vNOTES have shorter intraoperative times and length of stays, less postoperative pain, and more rapid recovery, which help mitigate higher costs incurred by commercial kits. While the vNOTES approach for ectopic pregnancy appears safe and efficacious, more robust data from larger randomized studies are needed.

研究目的:虽然腹腔镜方法是治疗宫外孕的首选手术方法,但vNOTES凭借其良好的光学可视性和避免腹部切口的优势,正在成为一种替代方法。作者比较了 vNOTES 与传统腹腔镜输卵管切除术在异位妊娠手术治疗中的人口统计学和结果数据:设计:病例对照研究患者:患有宫外孕且不适合接受腹腔镜手术的女性:测量和主要结果:患者平均年龄(29.7±53 天 vs 31.4±6.7 天)、胎次(1.2±1.1 vs 1.6±2.1)、体重指数(26.7±5.3 vs 27.2±5.4kg/m3)、孕龄(8.44±2.1 vs 7.3±1.7周)和βhCG水平(3725.4±3674.8 vs 4376.5±6493.4IU/升)在vNOTES与传统腹腔镜输卵管切除术患者之间具有可比性(p>0.05,t检验)。虽然估计失血量相似(218.2±491.7 vs 173.5±138.7毫升)(P>0.001),但vNOTES患者的手术时间(35.8±14.4 vs 75.8±19.7分钟)在统计学上更短(P结论:接受vNOTES治疗的患者术中时间和住院时间更短,术后疼痛更轻,恢复更快,这有助于降低商业套件所产生的较高成本。虽然vNOTES方法治疗宫外孕似乎安全有效,但还需要更大规模的随机研究提供更可靠的数据。
{"title":"A Case Control Study of vNOTES Versus Conventional Laparoscopic Salpingectomy for Ectopic Pregnancy.","authors":"Wai Yoong, Joachim Ho, Vanessa Mathieu, Sarah Wylie, Wasim Lodhi, Schahrazed Rouabhi","doi":"10.1016/j.jmig.2024.08.016","DOIUrl":"10.1016/j.jmig.2024.08.016","url":null,"abstract":"<p><strong>Study objective: </strong>While the laparoscopic approach is the surgical treatment of choice for ectopic pregnancy, vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) is emerging as an alternative route with its good optical visibility and avoidance of abdominal incisions. The authors compare demographics and outcome data of vNOTES vs conventional laparoscopic (CL) salpingectomy for the surgical management of ectopic pregnancy.</p><p><strong>Design: </strong>Case-control study.</p><p><strong>Setting: </strong>A London University hospital.</p><p><strong>Patients: </strong>Women with ectopic pregnancy unsuitable for medical management who underwent surgical management.</p><p><strong>Intervention: </strong>Twenty-five cases of vNOTES vs 25 CL salpingectomy.</p><p><strong>Measurements and main results: </strong>The mean patient age (29.7 ± 53 vs 31.4 ± 6.7 days), parity (1.2 ± 1.1 vs 1.6 ± 2.1), body mass index (26.7 ± 5.3 vs 27.2 ± 5.4 kg/m<sup>3</sup>), gestation age (8.44 ± 2.1 vs 7.3 ± 1.7 weeks) and β human chorionic gonadotrophin (βhCG) levels (3725.4 ± 3674.8 vs 4376.5 ± 6493.4 IU/liter) were comparable (p >.05, t test) between patients having vNOTES vs CL salpingectomy. While estimated blood loss was similar (218.2 ± 491.7 vs 173.5 ± 138.7 mL) (p >.001), vNOTES patients had a statistically shorter duration of surgery (35.8 ± 14.4 vs 75.8 ± 19.7 mins) (p <.001, t test) and length of stay (median: 11.5 vs 19.7 hours) (U = 72, p <.05, Mann-Whitney U test). Less patients in the vNOTES group required postoperative opioids (9% vs 25%), and the median visual analog score (/10) for pain at 24 hours was significantly lower (2.0 vs 4.0) (U = 75, p <.05, Mann-Whitney U test). Patients from the vNOTES group were able to return to normal daily activity 11.3 days quicker (5.8 ± 4.3 vs 17.1 ± 8.2 days) (p <.05, t test). vNOTES cases cost approximately USD150 more due to the price of the commercial kits but this is offset by reduced intraoperative time, length of stay and need for postprocedure analgesia.</p><p><strong>Conclusion: </strong>Patients undergoing vNOTES have shorter intraoperative times and length of stays, less postoperative pain, and more rapid recovery, which help mitigate higher costs incurred by commercial kits. While the vNOTES approach for ectopic pregnancy appears safe and efficacious, more robust data from larger randomized studies are needed.</p>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":"15-21"},"PeriodicalIF":3.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142108267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two-Year Follow-Up on Surgical Outcomes of vNOTES High Uterosacral Ligament Suspension for the Prophylaxis and Treatment of Pelvic Organ Prolapse: A Multicenter Prospective Cohort Study. vNOTES 高位输卵管韧带悬吊术预防和治疗盆腔脏器脱垂手术疗效的两年随访:一项多中心前瞻性队列研究。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2024-09-12 DOI: 10.1016/j.jmig.2024.09.007
Pınar Birol Ilter, Murat Yassa, Ozan Dogan, Arzu Bilge Tekin, Osman Samet Günkaya, Mahmut Yassa, Koray Gorkem Sacinti, Baydaa Alsannan, Hediye Dagdeviren, Niyazi Tug, Cihan Kaya

Study objective: We aimed to evaluate the medium-term outcomes of high uterosacral ligament suspension (HUSLS) with vaginal-assisted natural orifice transluminal endoscopic surgery (vNOTES) in patients either having pelvic organ prolapse or undergoing routine prophylaxis to prevent posthysterectomy vaginal vault prolapse.

Design: Multicenter prospective cohort study.

Setting: Three tertiary care hospitals.

Patients: Patients who received vNOTES-HUSLS between January 1, 2021, and January 1, 2023, were included in the study.

Interventions: vNOTES-HUSLS.

Measurements and main results: The data collected included surgery duration, intraoperative and postoperative complications, postoperative visual analog scores, and Female Sexual Function Index pain subdomain scores. The changes in prolapse levels were measured using modified Pelvic Organ Prolapse Quantifications System scores, including the C, Ba, and Bp scores recorded before surgery and during the postoperative follow-up examination. Patient satisfaction was assessed using the Patient Global Impression of Improvement questionnaire. The final analysis included 55 women. Of these, vNOTES-HUSLS was performed in 43 patients (78.2%) to treat apical prolapse, whereas the remaining 12 patients (21.8%) underwent prophylaxis after hysterectomy to prevent vaginal vault prolapse. The median follow-up period was 23.5 months, with a range of 12 to 37 months. Ba, C, and Bp points significantly improved in patients who underwent surgery for prolapse (p <.001). There was no recurrence in the apical compartment after vNOTES-HUSLS for both performed prophylactic and treatment purposes after hysterectomy. Two patients (3.6%) were diagnosed as having stage 3 anterior compartment prolapse. The overall vNOTES-HUSLS success rate was 96.4% at approximately 2-year follow-up. Bladder injury was detected as an intraoperative complication in 1 patient (1.8%). The overall satisfaction rate was 98.1% at the final follow-up.

Conclusion: vNOTES-HUSLS was effective in the treatment and prophylaxis of apical prolapse, demonstrating high anatomic success rates. The procedure demonstrated a low complication rate, with intraoperative and postoperative complications each observed in 1.8% of patients (n = 1).

研究目的我们旨在评估高位子宫骶韧带悬吊术(HUSLS)与阴道辅助自然孔腔镜内窥镜手术(vNOTES)在盆腔器官脱垂(POP)患者或接受常规预防措施以预防子宫切除术后阴道穹隆脱垂患者中的中期疗效:多中心前瞻性队列研究:三家三级甲等医院:干预措施:vNOTES-HUSLS 测量和主要结果:收集的数据包括手术时间、术中和术后并发症、术后视觉模拟评分(VAS)和女性性功能指数(FSFI)疼痛子域评分。脱垂程度的变化采用改良的 POP-Q 评分进行测量,包括术前和术后随访检查中记录的 C、Ba 和 Bp 评分。患者满意度采用患者整体改善印象(PGI-I)问卷进行评估。最终分析包括 55 名女性。其中43名患者(78.2%)接受了vNOTES-HUSLS治疗,以治疗阴道顶端脱垂,其余12名患者(21.8%)在子宫切除术后接受了预防性治疗,以防止阴道穹隆脱垂。中位随访期为 23.5 个月,范围为 12-37 个月。接受脱垂手术的患者的Ba、C和Bp点数均有明显改善(p结论:vNOTES-HUSLS在治疗和预防阴道顶端脱垂方面效果显著,解剖学成功率高。该手术的并发症发生率较低,术中和术后并发症发生率分别为1.8%(n=1)。
{"title":"Two-Year Follow-Up on Surgical Outcomes of vNOTES High Uterosacral Ligament Suspension for the Prophylaxis and Treatment of Pelvic Organ Prolapse: A Multicenter Prospective Cohort Study.","authors":"Pınar Birol Ilter, Murat Yassa, Ozan Dogan, Arzu Bilge Tekin, Osman Samet Günkaya, Mahmut Yassa, Koray Gorkem Sacinti, Baydaa Alsannan, Hediye Dagdeviren, Niyazi Tug, Cihan Kaya","doi":"10.1016/j.jmig.2024.09.007","DOIUrl":"10.1016/j.jmig.2024.09.007","url":null,"abstract":"<p><strong>Study objective: </strong>We aimed to evaluate the medium-term outcomes of high uterosacral ligament suspension (HUSLS) with vaginal-assisted natural orifice transluminal endoscopic surgery (vNOTES) in patients either having pelvic organ prolapse or undergoing routine prophylaxis to prevent posthysterectomy vaginal vault prolapse.</p><p><strong>Design: </strong>Multicenter prospective cohort study.</p><p><strong>Setting: </strong>Three tertiary care hospitals.</p><p><strong>Patients: </strong>Patients who received vNOTES-HUSLS between January 1, 2021, and January 1, 2023, were included in the study.</p><p><strong>Interventions: </strong>vNOTES-HUSLS.</p><p><strong>Measurements and main results: </strong>The data collected included surgery duration, intraoperative and postoperative complications, postoperative visual analog scores, and Female Sexual Function Index pain subdomain scores. The changes in prolapse levels were measured using modified Pelvic Organ Prolapse Quantifications System scores, including the C, Ba, and Bp scores recorded before surgery and during the postoperative follow-up examination. Patient satisfaction was assessed using the Patient Global Impression of Improvement questionnaire. The final analysis included 55 women. Of these, vNOTES-HUSLS was performed in 43 patients (78.2%) to treat apical prolapse, whereas the remaining 12 patients (21.8%) underwent prophylaxis after hysterectomy to prevent vaginal vault prolapse. The median follow-up period was 23.5 months, with a range of 12 to 37 months. Ba, C, and Bp points significantly improved in patients who underwent surgery for prolapse (p <.001). There was no recurrence in the apical compartment after vNOTES-HUSLS for both performed prophylactic and treatment purposes after hysterectomy. Two patients (3.6%) were diagnosed as having stage 3 anterior compartment prolapse. The overall vNOTES-HUSLS success rate was 96.4% at approximately 2-year follow-up. Bladder injury was detected as an intraoperative complication in 1 patient (1.8%). The overall satisfaction rate was 98.1% at the final follow-up.</p><p><strong>Conclusion: </strong>vNOTES-HUSLS was effective in the treatment and prophylaxis of apical prolapse, demonstrating high anatomic success rates. The procedure demonstrated a low complication rate, with intraoperative and postoperative complications each observed in 1.8% of patients (n = 1).</p>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":"39-48"},"PeriodicalIF":3.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiofrequency Ablation for the Treatment of Uterine Fibroids: A Systematic Review and Meta-Analysis by the AAGL Practice Committee. 射频消融治疗子宫肌瘤:AAGL实践委员会的系统回顾和荟萃分析。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2024-09-12 DOI: 10.1016/j.jmig.2024.09.011
Innie Chen, Jay M Berman, Ethan M Balk, Ian J Saldanha, Emilie Kowalczewski, Johnny Yi, Salena Zanotti, Mariam Al Hilli, Kimberly A Kho
<p><strong>Objective: </strong>To systematically review clinical and patient-reported outcomes after radiofrequency ablation (RFA) for the treatment of uterine fibroids.</p><p><strong>Data sources: </strong>We searched Medline, EMBASE, Cochrane Registry of Controlled Trials (CENTRAL) on September 8, 2023, and requested additional data from industry sources. We included published, peer-reviewed studies of patient-centered outcomes of RFA when used for symptomatic fibroids. Abstracts and potentially relevant full-text articles were screened and data were extracted regarding study characteristics, arms, outcomes, and results, together with risk of bias assessment.</p><p><strong>Methods of study selection: </strong>We included 30 studies published in 49 articles (3 randomized controlled trials, 1 nonrandomized comparative study, and 26 single-group studies, as well as 4 publications from the TRUST Study) with variable risks of bias.</p><p><strong>Tabulation, integration, and results: </strong>The study populations were demographically diverse and clinically heterogeneous. Across studies, RFA treatment was associated with fibroid volume reduction of 46.0% (95% confidence interval [CI] 52.1, 40.0; 11 studies) at 3 months and 65.4% (95% CI 74.7, 56.1; 10 studies) at 12 months. All studies reported a decrease in proportion of patients experiencing abnormal, heavy, or prolonged menstrual bleeding, with the most substantial improvement within the first 3 months. Meta-analyses of health-related quality of life scores demonstrated significant improvements in scores from baseline for Uterine Fibroid Symptoms and Quality of Life (53.4, 95% CI 48.2, 58.5; 19 studies), EuroQol-5 dimension (71.6, 95% CI 65.0, 78.1; 4 studies), and Symptom Severity Score (52.2, 95% CI 46.4, 58.1; 17 studies), with a peak at 6 months on the Uterine Fibroid Symptoms and Quality of Life scale (88.0, 95% CI 83.0, 92.9; 11 studies), a peak at 24 months on the EuroQol-5 dimension scale (88.3, 95% CI 86.0, 90.6; 2 studies), and a trough at 12 months for Symptom Severity Score (12.8, 95% CI 7.0, 18.6; 11 studies). Studies mostly demonstrated return to work and normal activities within 2 weeks. Reported unplanned hospitalizations were infrequent, and durations of hospital stay were generally short. Postprocedure complications were inconsistently reported but assessed overall to be infrequent. Long-term need for medical and surgical re-intervention varied. Post-RFA hysterectomy rates ranged from 2/205 (1.0%) to 15/62 (24.1%) with variable follow-up periods ranging from 45 days to 74 months. Most studies did not include patients who desired to maintain fertility; thus, reproductive data are insufficient for interpretation.</p><p><strong>Conclusion: </strong>There is a paucity of comparative studies, and the small number of RCTs are limited by lack of blinding. Few studies had the long-term follow-up time required to draw definitive conclusions regarding the durability of symptom relief. Howe
目的:系统回顾射频消融(RFA)治疗子宫肌瘤后的临床和患者报告结果:系统回顾射频消融(RFA)治疗子宫肌瘤后的临床和患者报告结果:我们于 2023 年 9 月 8 日检索了 Medline、EMBASE 和 Cochrane 对照试验注册中心 (CENTRAL),并要求行业来源提供更多数据。我们纳入了已发表的、经同行评审的、以患者为中心的、针对无症状子宫肌瘤的射频消融术治疗效果的研究。我们筛选了摘要和可能相关的全文文章,并提取了有关研究特点、方法、结果和结果的数据,同时进行了偏倚风险评估:我们纳入了 49 篇文章中发表的 30 项研究(3 项随机对照试验、1 项非随机对照研究和 26 项单组研究,以及 TRUST 研究中的 4 篇出版物),这些研究的偏倚风险各不相同:研究人群在人口统计学上各不相同,在临床上也不尽相同。在所有研究中,RFA 治疗与子宫肌瘤体积缩小有关,3 个月时缩小 46.0%(95% 置信区间 [CI] 52.1,40.0;11 项研究),12 个月时缩小 65.4%(95% 置信区间 [CI] 74.7,56.1;10 项研究)。所有研究都显示,出现月经异常、大量出血或经期延长的患者比例有所下降,其中头 3 个月的改善最为显著。对健康相关生活质量(HRQOL)评分进行的元分析表明,子宫肌瘤症状和生活质量[UFS-QOL](53.4,95% CI 48.2,58.5;19 项研究)、EuroQol 5 Dimension [EQ-5D](71.6,95% CI 65.0,78.1;4 项研究)、症状和生活质量[UFS-QOL](53.4,95% CI 48.2,58.5;19 项研究)的评分与基线相比均有显著改善。UFS-QOL量表的峰值出现在6个月时(88.0,95% CI 83.0,92.9;11项研究),EuroQol-5D量表的峰值出现在24个月时(88.3,95% CI 86.0,90.6;2项研究),SSS的峰值出现在12个月时(12.8,95% CI 7.0,18.6;11项研究)。大多数研究表明,患者可在 2 周内恢复工作和正常活动。非计划住院的报告并不常见,住院时间一般较短。手术后并发症的报告不一致,但总体上评估为不常见。对医疗和手术再干预的长期需求各不相同。RFA术后子宫切除率从2/205(1.0%)到15/62(24.1%)不等,随访时间从45天到74个月不等。大多数研究不包括希望保持生育能力的患者;因此,生殖数据不足以进行解释:结论:比较性研究很少,少量的研究性临床试验因缺乏盲法而受到限制。很少有研究需要长期随访才能就症状缓解的持久性得出明确结论。不过,尽管存在这些局限性,但对于 RFA 治疗后的几项重要临床指标,如肌瘤体积缩小、子宫出血改善和生活质量提高等,总体上还是达成了一致。为了更好地描述在子宫肌瘤患者中使用 RFA 的特点,今后需要进行高质量的随机对照试验,并采用标准化的结果测量方法。
{"title":"Radiofrequency Ablation for the Treatment of Uterine Fibroids: A Systematic Review and Meta-Analysis by the AAGL Practice Committee.","authors":"Innie Chen, Jay M Berman, Ethan M Balk, Ian J Saldanha, Emilie Kowalczewski, Johnny Yi, Salena Zanotti, Mariam Al Hilli, Kimberly A Kho","doi":"10.1016/j.jmig.2024.09.011","DOIUrl":"10.1016/j.jmig.2024.09.011","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To systematically review clinical and patient-reported outcomes after radiofrequency ablation (RFA) for the treatment of uterine fibroids.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Data sources: &lt;/strong&gt;We searched Medline, EMBASE, Cochrane Registry of Controlled Trials (CENTRAL) on September 8, 2023, and requested additional data from industry sources. We included published, peer-reviewed studies of patient-centered outcomes of RFA when used for symptomatic fibroids. Abstracts and potentially relevant full-text articles were screened and data were extracted regarding study characteristics, arms, outcomes, and results, together with risk of bias assessment.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods of study selection: &lt;/strong&gt;We included 30 studies published in 49 articles (3 randomized controlled trials, 1 nonrandomized comparative study, and 26 single-group studies, as well as 4 publications from the TRUST Study) with variable risks of bias.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Tabulation, integration, and results: &lt;/strong&gt;The study populations were demographically diverse and clinically heterogeneous. Across studies, RFA treatment was associated with fibroid volume reduction of 46.0% (95% confidence interval [CI] 52.1, 40.0; 11 studies) at 3 months and 65.4% (95% CI 74.7, 56.1; 10 studies) at 12 months. All studies reported a decrease in proportion of patients experiencing abnormal, heavy, or prolonged menstrual bleeding, with the most substantial improvement within the first 3 months. Meta-analyses of health-related quality of life scores demonstrated significant improvements in scores from baseline for Uterine Fibroid Symptoms and Quality of Life (53.4, 95% CI 48.2, 58.5; 19 studies), EuroQol-5 dimension (71.6, 95% CI 65.0, 78.1; 4 studies), and Symptom Severity Score (52.2, 95% CI 46.4, 58.1; 17 studies), with a peak at 6 months on the Uterine Fibroid Symptoms and Quality of Life scale (88.0, 95% CI 83.0, 92.9; 11 studies), a peak at 24 months on the EuroQol-5 dimension scale (88.3, 95% CI 86.0, 90.6; 2 studies), and a trough at 12 months for Symptom Severity Score (12.8, 95% CI 7.0, 18.6; 11 studies). Studies mostly demonstrated return to work and normal activities within 2 weeks. Reported unplanned hospitalizations were infrequent, and durations of hospital stay were generally short. Postprocedure complications were inconsistently reported but assessed overall to be infrequent. Long-term need for medical and surgical re-intervention varied. Post-RFA hysterectomy rates ranged from 2/205 (1.0%) to 15/62 (24.1%) with variable follow-up periods ranging from 45 days to 74 months. Most studies did not include patients who desired to maintain fertility; thus, reproductive data are insufficient for interpretation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;There is a paucity of comparative studies, and the small number of RCTs are limited by lack of blinding. Few studies had the long-term follow-up time required to draw definitive conclusions regarding the durability of symptom relief. Howe","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":"74-91"},"PeriodicalIF":3.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meigs' Syndrome: A Minimally Invasive Approach for a Large Ovarian Mass. 梅格斯综合征:微创方法治疗巨大卵巢肿块
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2024-07-22 DOI: 10.1016/j.jmig.2024.07.017
Issac Domenech-Gonzalez, Connor Wang, Sonya Bharadwa, Dario Roque
{"title":"Meigs' Syndrome: A Minimally Invasive Approach for a Large Ovarian Mass.","authors":"Issac Domenech-Gonzalez, Connor Wang, Sonya Bharadwa, Dario Roque","doi":"10.1016/j.jmig.2024.07.017","DOIUrl":"10.1016/j.jmig.2024.07.017","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":"3-4"},"PeriodicalIF":3.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141759287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-Intensity Focused Ultrasound Ablation Combined With Hysteroscopy for the Treatment of Uterine Arteriovenous Fistula Associated With Retained Products of Conception: A Prospective Cohort Study. 高强度聚焦超声消融联合宫腔镜治疗与受孕产物滞留相关的子宫动静脉瘘:一项前瞻性队列研究。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2024-09-12 DOI: 10.1016/j.jmig.2024.09.010
Lili Xu, Haining Chen, Yanju Xiao, Zhifeng Jiang, Jing Zhang, Yanming Jiang, Dan Ling

Study objective: To evaluate the efficacy of combining high-intensity focused ultrasound (HIFU) ablation with hysteroscopic removal of retained products of conception in the presence of a uterine arteriovenous fistula (UAVF).

Design: Prospective cohort study SETTING: Tertiary hospital.

Patients: Seventeen patients with UAVF and retained products of conception.

Interventions: HIFU ablation combined with hysteroscopic removal of retained products of conception.

Measurements and main results: All patients presented with irregular vaginal bleeding following pregnancy termination and were not responsive to medical treatment. Patients were confirmed to have a UAVF along with concurrent intrauterine residue using three-dimensional color Doppler ultrasonography, uterine angiography, or pelvic-enhanced magnetic resonance imaging; and demonstrated a poor response to medical treatment. Under real-time ultrasound guidance, HIFU was used to ablate the arteriovenous malformation region. Patients underwent hysteroscopic removal of retained products of conception; the removed tissue was subjected to pathological examination. All patients underwent monthly uterine color Doppler ultrasound examinations and menstrual status follow-up within 3 months postoperatively and showed normal menstrual recovery without signs of arteriovenous malformations on ultrasonography. Pathological examination of the tissues removed during hysteroscopic clearance revealed characteristics consistent with pregnancy, with abnormal blood vessels in some tissues. All patients experienced normal menstrual recovery postoperatively, without intrauterine adhesions.

Conclusion: Combining HIFU ablation with postoperative hysteroscopic surgery effectively treats pregnancy-related UAVF with minimal complications and preserves fertility, it offers an additional treatment option for patients wanting future fertility.

目的评估在存在子宫动静脉瘘(UAVF)的情况下,将高强度聚焦超声(HIFU)消融术与宫腔镜清除受孕产物相结合的疗效:前瞻性队列研究:参与者干预措施: HIFU消融术联合子宫动静脉瘘治疗:结果:所有患者均在终止妊娠后出现不规则阴道出血,且对药物治疗无反应。通过三维彩色多普勒超声波检查、子宫血管造影术或盆腔增强磁共振成像检查,患者被证实患有UAVF,同时伴有宫内残留物;且对药物治疗反应不佳。在实时超声引导下,采用 HIFU 对动静脉畸形区域进行消融。患者在宫腔镜下取出滞留的受孕产物,并对取出的组织进行病理检查。所有患者均在术后3个月内接受了每月一次的子宫彩色多普勒超声检查和月经状况随访,超声检查结果显示月经恢复正常,无动静脉畸形迹象。宫腔镜清宫术中取出的组织病理检查显示与妊娠特征一致,部分组织中存在异常血管。所有患者术后月经恢复正常,无宫腔内粘连:结论:将 HIFU 消融术与术后宫腔镜手术相结合,可有效治疗与妊娠相关的子宫内膜异位症,且并发症极少,还能保留生育能力;为希望今后生育的患者提供了一种额外的治疗选择。
{"title":"High-Intensity Focused Ultrasound Ablation Combined With Hysteroscopy for the Treatment of Uterine Arteriovenous Fistula Associated With Retained Products of Conception: A Prospective Cohort Study.","authors":"Lili Xu, Haining Chen, Yanju Xiao, Zhifeng Jiang, Jing Zhang, Yanming Jiang, Dan Ling","doi":"10.1016/j.jmig.2024.09.010","DOIUrl":"10.1016/j.jmig.2024.09.010","url":null,"abstract":"<p><strong>Study objective: </strong>To evaluate the efficacy of combining high-intensity focused ultrasound (HIFU) ablation with hysteroscopic removal of retained products of conception in the presence of a uterine arteriovenous fistula (UAVF).</p><p><strong>Design: </strong>Prospective cohort study SETTING: Tertiary hospital.</p><p><strong>Patients: </strong>Seventeen patients with UAVF and retained products of conception.</p><p><strong>Interventions: </strong>HIFU ablation combined with hysteroscopic removal of retained products of conception.</p><p><strong>Measurements and main results: </strong>All patients presented with irregular vaginal bleeding following pregnancy termination and were not responsive to medical treatment. Patients were confirmed to have a UAVF along with concurrent intrauterine residue using three-dimensional color Doppler ultrasonography, uterine angiography, or pelvic-enhanced magnetic resonance imaging; and demonstrated a poor response to medical treatment. Under real-time ultrasound guidance, HIFU was used to ablate the arteriovenous malformation region. Patients underwent hysteroscopic removal of retained products of conception; the removed tissue was subjected to pathological examination. All patients underwent monthly uterine color Doppler ultrasound examinations and menstrual status follow-up within 3 months postoperatively and showed normal menstrual recovery without signs of arteriovenous malformations on ultrasonography. Pathological examination of the tissues removed during hysteroscopic clearance revealed characteristics consistent with pregnancy, with abnormal blood vessels in some tissues. All patients experienced normal menstrual recovery postoperatively, without intrauterine adhesions.</p><p><strong>Conclusion: </strong>Combining HIFU ablation with postoperative hysteroscopic surgery effectively treats pregnancy-related UAVF with minimal complications and preserves fertility, it offers an additional treatment option for patients wanting future fertility.</p>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":"64-71"},"PeriodicalIF":3.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimally invasive retrieval of a mature jaw bone and teeth from a dermoid cyst. 从皮样囊肿中取出成熟颌骨和牙齿的微创手术。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-30 DOI: 10.1016/j.jmig.2024.12.014
Houyu Yang, Yuanjunzi Shi, Gang Ji

The manuscript showcases images of an extensive ovarian dermoid cyst harboring a mandibular structure containing three teeth. To date, only six case reports have described teeth within a mandibular structure in a dermoid cyst. To the best of our knowledge, this represents the first documented instance of a dermoid cyst with a mandibular structure containing teeth managed through transumbilical laparoendoscopic single-site surgery.

手稿展示了一个广泛的卵巢皮样囊肿的图像窝藏下颌骨结构包含三颗牙齿。到目前为止,只有六个病例报告描述了牙齿在下颌骨结构皮样囊肿。据我们所知,这是第一例记录在案的皮样囊肿与下颌骨结构包含牙齿通过经脐腹腔镜单部位手术处理。
{"title":"Minimally invasive retrieval of a mature jaw bone and teeth from a dermoid cyst.","authors":"Houyu Yang, Yuanjunzi Shi, Gang Ji","doi":"10.1016/j.jmig.2024.12.014","DOIUrl":"https://doi.org/10.1016/j.jmig.2024.12.014","url":null,"abstract":"<p><p>The manuscript showcases images of an extensive ovarian dermoid cyst harboring a mandibular structure containing three teeth. To date, only six case reports have described teeth within a mandibular structure in a dermoid cyst. To the best of our knowledge, this represents the first documented instance of a dermoid cyst with a mandibular structure containing teeth managed through transumbilical laparoendoscopic single-site surgery.</p>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142914600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reliability of an Electronic Uterine Diagram to Standardize Intrauterine Adhesion Scoring. 电子子宫图对宫内粘连评分标准化的可靠性。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-30 DOI: 10.1016/j.jmig.2024.12.016
Laura Miquel, Aubert Agostini, Anderson Loundou, Salima Daoud, Elisabetta Mazza, Malcolm G Munro, Patrice Crochet

Study objective: To study the inter-rater reliability of an electronic complementary uterine diagram (electronic American Fertility Society [eAFS] freely available at https://bit.ly/eAFS-score) in comparison with the conventional American Fertility Society (cAFS) intrauterine adhesion (IUA) scoring system. As a secondary aim, we wanted to assess the intra-rater reliability of these tools.

Design: This was an observational cross-over study with a nested test-retest design.

Setting: Self-identified gynecologists who performed diagnostic hysteroscopy as part of their routine practice were asked to score IUA on 7 preselected videos using both cAFS and eAFS tools in 2 separate rounds. The order of use of tools was determined at random. Gynecologists who agreed to be involved in a third round were asked to use the tool they were allocated to in the first round to assess intra-rater variability.

Patients: No patients were recruited for the purpose of this study.

Measurements and main results: Inter-rater agreement between evaluators when using eAFS and cAFS for IUA scoring. Overall, the inter-rater agreement was fair (0.25; confidence interval [CI], 0.17-0.34) for cAFS and moderate (0.53; CI, 0.48-0.58) for the eAFS tool. The biggest difference between both tools was seen in the "extent of cavity involved" component, which was fair (0.28; CI, 0.21-0.35) vs substantial (0.71; CI, 0.64-0.78) for cAFS vs eAFS, respectively. Moreover, agreement coefficients were comparable among "expert" and "non-expert" evaluators with the use of the eAFS tool. In addition, intra-rater perfect agreement was higher with the use of eAFS than cAFS (38% vs 32.5%).

Conclusion: The current AFS IUA scoring system has fair inter-rater agreement. However, using a complementary electronic uterine diagram increased this agreement from fair to moderate overall and from fair to substantial in the "extent of adhesions" domain of the tool. The use of the electronic diagram also improved inter-rater agreement among non-experts making it comparable with that of experts.

研究目的:研究电子补充子宫图(eAFS)与传统美国生育学会宫内粘连(IUA)评分系统(cAFS)的可靠性。作为次要目标,我们想评估这些工具的内部可靠性。设计:这是一项观察性交叉研究,采用嵌套测试再测试设计。设置:自我认定的妇科医生进行诊断性宫腔镜检查作为其常规实践的一部分,被要求在两轮中使用cAFS和eAFS工具对7个预选视频进行IUA评分。工具的使用顺序是随机确定的。同意参与第三轮的妇科医生被要求使用他们在第一轮中分配到的工具来评估内部变异性。患者:本研究未招募患者。测量:当使用eAFS和cAFS进行IUA评分时,评估者之间的评分一致性。主要结果:总体而言,评价间一致性为公平(cAFS为0.25 [CI 0.17 - 0.34]), eAFS工具为中等(0.53 [CI 0.48 -0.58])。两种工具之间最大的差异是“受累腔的范围”成分,cAFS和eAFS的差异分别为一般(0.28 [CI 0.21 - 0.35])和大量(0.71 [CI 0.64 - 0.78])。此外,使用eAFS工具,“专家”和“非专家”评估者之间的一致性系数可比较。此外,与使用cAFS相比,使用eAFS的评分者内部完全一致性更高(38%对32.5%)。结论:目前的AFS IUA评分系统具有公平的评分员间一致性。然而,使用互补的电子子宫图将这种一致性从一般提高到中等,在工具的“粘连程度”领域从一般提高到大量。电子图表的使用也改善了非专家之间的评价者之间的协议,使其与专家的协议相当。
{"title":"Reliability of an Electronic Uterine Diagram to Standardize Intrauterine Adhesion Scoring.","authors":"Laura Miquel, Aubert Agostini, Anderson Loundou, Salima Daoud, Elisabetta Mazza, Malcolm G Munro, Patrice Crochet","doi":"10.1016/j.jmig.2024.12.016","DOIUrl":"10.1016/j.jmig.2024.12.016","url":null,"abstract":"<p><strong>Study objective: </strong>To study the inter-rater reliability of an electronic complementary uterine diagram (electronic American Fertility Society [eAFS] freely available at https://bit.ly/eAFS-score) in comparison with the conventional American Fertility Society (cAFS) intrauterine adhesion (IUA) scoring system. As a secondary aim, we wanted to assess the intra-rater reliability of these tools.</p><p><strong>Design: </strong>This was an observational cross-over study with a nested test-retest design.</p><p><strong>Setting: </strong>Self-identified gynecologists who performed diagnostic hysteroscopy as part of their routine practice were asked to score IUA on 7 preselected videos using both cAFS and eAFS tools in 2 separate rounds. The order of use of tools was determined at random. Gynecologists who agreed to be involved in a third round were asked to use the tool they were allocated to in the first round to assess intra-rater variability.</p><p><strong>Patients: </strong>No patients were recruited for the purpose of this study.</p><p><strong>Measurements and main results: </strong>Inter-rater agreement between evaluators when using eAFS and cAFS for IUA scoring. Overall, the inter-rater agreement was fair (0.25; confidence interval [CI], 0.17-0.34) for cAFS and moderate (0.53; CI, 0.48-0.58) for the eAFS tool. The biggest difference between both tools was seen in the \"extent of cavity involved\" component, which was fair (0.28; CI, 0.21-0.35) vs substantial (0.71; CI, 0.64-0.78) for cAFS vs eAFS, respectively. Moreover, agreement coefficients were comparable among \"expert\" and \"non-expert\" evaluators with the use of the eAFS tool. In addition, intra-rater perfect agreement was higher with the use of eAFS than cAFS (38% vs 32.5%).</p><p><strong>Conclusion: </strong>The current AFS IUA scoring system has fair inter-rater agreement. However, using a complementary electronic uterine diagram increased this agreement from fair to moderate overall and from fair to substantial in the \"extent of adhesions\" domain of the tool. The use of the electronic diagram also improved inter-rater agreement among non-experts making it comparable with that of experts.</p>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142914863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heterotopic Cornual and Tubal Ipsilateral Pregnancies Following Dual Embryo Transfer. 双胚胎移植后异位角和输卵管同侧妊娠。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-30 DOI: 10.1016/j.jmig.2024.12.019
Sida Chen, Yanmei Sun, Yang Song, Jing Xiao
{"title":"Heterotopic Cornual and Tubal Ipsilateral Pregnancies Following Dual Embryo Transfer.","authors":"Sida Chen, Yanmei Sun, Yang Song, Jing Xiao","doi":"10.1016/j.jmig.2024.12.019","DOIUrl":"https://doi.org/10.1016/j.jmig.2024.12.019","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142914436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of minimally invasive gynecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1